- Recent Advances of Biliary Stent Management
-
Kida M, Miyazawa S, Iwai T, Ikeda H, Takezawa M, Kikuchi H, Watanabe M, Imaizumi H, Koizumi W
- KMID: 1372869
- Korean J Radiol.
- 2012 Feb;13(Suppl 1):S62-S66.
- doi: 10.3348/kjr.2012.13.S1.S62
Recent progress in chemotherapy has prolonged the survival of patients with malignant biliary strictures, leading to increased rates of stent occlusion. Even we employed metallic stents which contributed to higher... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
-
Maeda T, Sakuraba H, Hiraga H, Yoshida S, Kakuta Y, Kikuchi H, Kawaguchi S, Hasui K, Tatsuta T, Chinda D, Mikami T, Fukuda S
- KMID: 2525076
- Intest Res.
- 2022 Jan;20(1):90-100.
- doi: 10.5217/ir.2020.00133
Background/Aims: Thiopurines are key drugs for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Recently, NUDT15 polymorphism (R139C, c.415C > T) has been shown to be... -
- CITED
-
- Close
- SHARE
-
- Close
